Table 4.
PAHs a | DWTP | WWTP | |||||
---|---|---|---|---|---|---|---|
DW 1 | DW 2 | WW 1 | WW2 | WW3 | WW4 | ||
2-ring | NA | 0.0117 | ND (0.0008) e | 0.0981 | 0.0185 | 0.0290 | 0.0518 |
3-ring | ACY | ND (0.0007) e | ND (0.0002) e | 0.0285 | 0.0009 | 0.0058 | 0.0146 |
ACE | 0.0019 | 0.0017 | 0.0064 | 0.0017 | 0.0028 | 0.0117 | |
FL | 0.0054 | 0.0043 | 0.0104 | 0.0034 | 0.0139 | 0.0097 | |
PH | 0.0201 | 0.0204 | 0.1291 | 0.0114 | 0.0511 | 0.1018 | |
AN | 0.0396 | ND (0.0005) e | 0.0827 | 0.0122 | 0.0384 | 0.0683 | |
4-ring | FLU | 0.0067 | 0.0075 | 0.1516 | 0.0129 | 0.0829 | 0.1275 |
PY | 0.0081 | 0.0100 | 0.1475 | 0.1336 | 0.0657 | 0.1195 | |
BaA b | 0.0119 | ND (0.0014) e | 0.0568 | 0.0163 | 0.0236 | 0.0382 | |
CH b | 0.0107 | 0.0093 | 0.0884 | 0.0924 | 0.0452 | 0.0622 | |
5-ring | BbF b | 0.0015 | 0.0042 | 0.0301 | 0.0087 | 0.0195 | 0.0257 |
BkF b | 0.0018 | ND (0.0006) e | 0.0297 | 0.0097 | 0.0186 | 0.0255 | |
BaP b | 0.0059 | ND (0.0011) e | 0.0685 | 0.0070 | 0.0373 | 0.0527 | |
IP b | 0.0049 | ND (0.0010) e | 0.0754 | 0.0640 | 0.0526 | 0.0750 | |
6-ring | DBA b | ND (0.0042) e | ND (0.0002) e | 0.0228 | 0.0434 | 0.0134 | 0.0210 |
BP | 0.0008 | 0.0037 | 0.0408 | 0.0997 | 0.0344 | 0.0635 | |
ΣPAHs c | 0.1357 | 0.0668 | 1.0666 | 0.5357 | 0.5342 | 0.8684 | |
ΣLPAHs c | 0.0793 | 0.0279 | 0.0355 | 0.0480 | 0.1410 | 0.2577 | |
ΣHPAHs c | 0.0564 | 0.0389 | 0.7116 | 0.4877 | 0.3931 | 0.6107 | |
ΣLPAHs/ΣHPAHs | 1.40 | 0.72 | 0.50 | 0.10 | 0.36 | 0.42 | |
ΣCPAHs c | 0.0409 | 0.0177 | 0.3716 | 0.2415 | 0.2101 | 0.3002 | |
ΣTEQ d | 0.0041 | 0.0018 | 0.0372 | 0.0242 | 0.0210 | 0.0300 |
a The definitions of compound abbreviation see Table 2; b Carcinogenic PAHs; c ΣPAHs: sum of 2–6-ring PAHs; ΣLPAHs: sum of 2- & 3-ring PAHs; ΣHPAHs: sum of 4-, 5-, and 6-ring PAHs; ΣCPAHs: sum of 7 carcinogenic PAHs; d ΣTEQ: sum of 7 carcinogenic PAHs BaP toxic equivalence quotient; e The measured value is less than the detection limit.